stuartscott8900, I couldn't really follow your post very well as it was going in a lot of different directions. I know you are a newbee as you just joined investorshub, and have a total of 28 posts. If you don't mind, could you please try to repost your thoughts and go right to the point you were trying to make? Thanks..
Except when the EPIC data comes out, early approval follows, and we walk away with NVS' 5 billion in Revs on a highly accelerated path....no bigger game changer in biotech today I dont think. We just shortened your 3-4 year timeline significantly.